Xencor Q4 EPS $1.21 May Not Compare To $(0.10) Estimate, Sales $154.02M Beat $71.22M Estimate
Xencor (NASDAQ:XNCR) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $(0.10) by 1310 percent. This is a 604.17 percent increase over losses of $(0.24) per share from the same
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
BMO Capital Initiates Coverage On Xencor with Outperform Rating
BMO Capital analyst Etzer Darout initiates coverage on Xencor (NASDAQ:XNCR) with a Outperform rating.
HC Wainwright & Co. Initiates Coverage On Xencor with Buy Rating, Announces Price Target of $61
HC Wainwright & Co. analyst Michael King initiates coverage on Xencor (NASDAQ:XNCR) with a Buy rating and announces Price Target of $61.
Pfizer Sues Former Employee For Stealing Confidential Info On Its Megablockbuster COVID-19 Vaccine
Pfizer Inc (NYSE: PFE) has sued its former associate director of clinical statistics in a California court to get a handle on allegedly stolen information. The Company's lawsuit focuses on the COVID-19 vaccine, Comirnaty, and two cancer monoclonal antibodies.